| Q35718562 | ART uptake, its timing and relation to anti-tuberculosis treatment outcomes among HIV-infected TB patients. |
| Q33286208 | Acceptability of HIV counselling and testing among tuberculosis patients in south Ethiopia |
| Q33540310 | Assessing the accessibility of HIV care packages among tuberculosis patients in the Northwest Region, Cameroon |
| Q28084544 | Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review |
| Q35939235 | Challenges of Childhood TB/HIV Management in Malawi |
| Q35972660 | Comparative Yield of Different Diagnostic Tests for Tuberculosis among People Living with HIV in Western Kenya |
| Q35211308 | Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China |
| Q37452075 | Cotrimoxazole prophylaxis and tuberculosis risk among people living with HIV. |
| Q36877242 | Diagnostic and management challenges for childhood tuberculosis in the era of HIV. |
| Q34359439 | Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda |
| Q36982435 | Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania |
| Q33757222 | Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention. |
| Q35938001 | Epidemiology of HIV/AIDS in adults in Malawi |
| Q26824501 | HIV and tuberculosis--science and implementation to turn the tide and reduce deaths |
| Q37757644 | Health-system strengthening and tuberculosis control |
| Q46743402 | How can the community contribute in the fight against HIV/AIDS and tuberculosis? An example from a rural district in Malawi |
| Q45385323 | Human immunodeficiency virus testing among patients with tuberculosis at a university hospital in Taiwan, 2000 to 2006. |
| Q33793347 | Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV. |
| Q36480371 | Improved survival with co-trimoxazole prophylaxis among people living with HIV/AIDS who initiated antiretroviral treatment in Henan Province, China |
| Q46927802 | Incidence of neutropenia in HIV-infected African adults receiving co-trimoxazole prophylaxis: a 6-year cohort study in Abidjan, Côte d'Ivoire |
| Q36131547 | Independent predictors of tuberculosis mortality in a high HIV prevalence setting: a retrospective cohort study |
| Q37950537 | Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review |
| Q58112932 | Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study |
| Q36635875 | International standards for tuberculosis care |
| Q38567639 | Is operational research delivering the goods? The journey to success in low-income countries |
| Q56989629 | Knowledge and acceptability of HAART among TB patients in Durban, South Africa |
| Q35207311 | Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis |
| Q33471454 | Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India |
| Q33548091 | Low HIV testing rates among tuberculosis patients in Kampala, Uganda |
| Q45292709 | Low plasma selenium concentrations, high plasma human immunodeficiency virus load and high interleukin-6 concentrations are risk factors associated with anemia in adults presenting with pulmonary tuberculosis in Zomba district, Malawi |
| Q57340232 | Male youth and Voluntary Counseling and HIV-Testing: the case of Malawi and Uganda |
| Q34455442 | Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review |
| Q33573384 | Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals |
| Q30501533 | National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links |
| Q33973050 | Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV. |
| Q37619854 | Operational research in low-income countries: what, why, and how? |
| Q33521250 | Perceptions of tuberculosis patients on provider-initiated HIV testing and counseling--a study from south India |
| Q35734934 | Potentially Modifiable Factors Associated with Death of Infants and Children with Severe Pneumonia Routinely Managed in District Hospitals in Malawi. |
| Q64272192 | Public Health Panorama of Operational Research: A Narrative Review |
| Q34209707 | Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa |
| Q37131431 | Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial |
| Q21133667 | Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review |
| Q36834927 | Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment |
| Q37524217 | Scale-up of ART in Malawi has reduced case notification rates in HIV-positive and HIV-negative tuberculosis |
| Q36952777 | Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries. |
| Q46439467 | South African TB nurses' experiences of provider-initiated HIV counseling and testing in the Eastern Cape Province: a qualitative study |
| Q37757652 | The HIV-associated tuberculosis epidemic--when will we act? |
| Q35665530 | The complex relationship between human immunodeficiency virus infection and death in adults being treated for tuberculosis in Cape Town, South Africa |
| Q36657522 | The development of health policy in Malawi: the influence of context, evidence and links in the creation of a national policy for cotrimoxazole prophylaxis |
| Q35571598 | The financial cost of doctors emigrating from sub-Saharan Africa: human capital analysis |
| Q36548072 | Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration |
| Q34734600 | Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy |
| Q31048728 | Treatment outcomes of adult patients with recurrent tuberculosis in relation to HIV status in Zimbabwe: a retrospective record review |
| Q34996955 | Trends in and determinants of loss to follow up and early mortality in a rapid expansion of the antiretroviral treatment program in Vietnam: findings from 13 outpatient clinics |
| Q36274930 | Tuberculosis control in the era of HIV. |
| Q36424963 | Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment |
| Q36648431 | Utilization rates and perceptions of (VCT) services in Kisii Central District, Kenya |